Breast Cancer Clinical Trial
— MICAOfficial title:
A Prospective, Randomized Controlled Trial of Mindfulness-based Stress Reduction (MBSR) Among Women Operated for Breast Cancer
Verified date | June 2015 |
Source | Danish Cancer Society |
Contact | n/a |
Is FDA regulated | No |
Health authority | Denmark: Danish Dataprotection Agency |
Study type | Interventional |
The number of Danish women treated for breast cancer rise every year, though survival rates
have improved, women can still expect to experience the diverse late effects reported by
this group of patients. Mindfulness labels the ability to be aware of the present moment -
thereby avoiding speculations about both past and present. Mindfulness based
stress-reduction (MBSR) is an 8-week program, covering 24 contact-hours and 45 minutes daily
home practice. The program aims at developing participants' coping resources and developing
participants' mindful awareness. Thus the program consists of guided meditations, guided
body scan(a specific awareness exercise)and through meditation, yoga and psychoeducation
concerning stress and stress-reactions, while meditation and bodyscan is practiced at home
by the use of specific audio-CDs guiding the patient. The MBSR-program have shoved promising
results among patients with anxiety-disorders, depression and chronic pain. Smaller studies
have also found positive effects of the program among cancer patients. The investigators
want to evaluate the effect of the MBSR program on levels of anxiety and depression as well
as the possible influence of mindfulness training on health behaviors and existential
concerns. The study are based on the following hypotheses:
- report of anxiety and depression will decrease among cases
- better compliance will lead to more decrease in levels of anxiety and depression
- cases will make lifestyle changes suitable with recommendations for BC patients in
post-treatment phase of the illness
- decreased level of anxiety and depression will reflect improved spiritual well-being
- improved spiritual wellbeing will lead to decreased report of physical symptoms
All participants in this randomized controlled trial will fill out questionnaires at
enrollment and as 1, 6 and 12 months follow-up. Based on results from this trial clinicians
and patients will be able to make decisions regarding post-treatment psychosocial
intervention and researchers will have initial evidence of the effect of the intervention
and thus possible indications for research on mindfulness among patients diagnosed with
cancer at other stages or sites.
Status | Completed |
Enrollment | 336 |
Est. completion date | November 2011 |
Est. primary completion date | December 2010 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: - women 18-75 years - operated for breast cancer stage I-III at either Herlev hospital (F-118) or Ringsted sygehus (Mammakirurgisk Klinik) after september 2006 - speak and read danish Exclusion Criteria: - other cancers - diseases or disabilities hindering MBSR-participation - active treatment for psychiatric disease including alcohol abuse |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Country | Name | City | State |
---|---|---|---|
Denmark | Danish Cancer Sociaty Research Center, Suvivorship | Copenhagen |
Lead Sponsor | Collaborator |
---|---|
Danish Cancer Society | Herlev Hospital, University of Copenhagen |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | SCL-90r Depression and anxiety subscales | baseline - 12 months | No | |
Secondary | clinical databases, containing information on BC (stage, treatment protocol) and comorbidity (other acute or chronic physical or psychiatric diseases) | baseline - 12 months | No | |
Secondary | standardized validated psychometric scales | SCL-90r, NEO-PIR, FACIT-Sp, CES-D,MDI, WHO5, Inter99, IPAQ, FFMQ, BCPT-BEES, | baseline - 12 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A |